HK1064947A1 - Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma - Google Patents

Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma

Info

Publication number
HK1064947A1
HK1064947A1 HK04107793A HK04107793A HK1064947A1 HK 1064947 A1 HK1064947 A1 HK 1064947A1 HK 04107793 A HK04107793 A HK 04107793A HK 04107793 A HK04107793 A HK 04107793A HK 1064947 A1 HK1064947 A1 HK 1064947A1
Authority
HK
Hong Kong
Prior art keywords
retinoprotecti
glaucoma
agents
treatment
feminizing estrogens
Prior art date
Application number
HK04107793A
Other languages
English (en)
Inventor
Lok-Hou Pang
Abbot F Clark
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of HK1064947A1 publication Critical patent/HK1064947A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK04107793A 2001-09-05 2004-10-11 Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma HK1064947A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31722501P 2001-09-05 2001-09-05
PCT/US2002/027969 WO2003020284A1 (en) 2001-09-05 2002-09-03 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
HK1064947A1 true HK1064947A1 (en) 2005-02-08

Family

ID=23232682

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04107793A HK1064947A1 (en) 2001-09-05 2004-10-11 Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma

Country Status (17)

Country Link
EP (1) EP1423125B1 (xx)
JP (1) JP2005501888A (xx)
KR (1) KR100894385B1 (xx)
CN (1) CN1551773A (xx)
AR (1) AR038451A1 (xx)
AT (1) ATE371455T1 (xx)
AU (1) AU2002326807B2 (xx)
BR (1) BR0212274A (xx)
CA (1) CA2458468C (xx)
DE (1) DE60222143T2 (xx)
ES (1) ES2289134T3 (xx)
HK (1) HK1064947A1 (xx)
MX (1) MXPA04002098A (xx)
PL (1) PL206249B1 (xx)
TW (1) TWI320712B (xx)
WO (1) WO2003020284A1 (xx)
ZA (1) ZA200401313B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214806A1 (en) 2002-09-03 2004-10-28 Iok-Hou Pang Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
EP2292239A3 (en) * 2003-04-18 2011-03-30 Advanced Medicine Research Institute Remedies for diseases to be applied to eye
WO2004093882A1 (ja) * 2003-04-18 2004-11-04 Advanced Medicine Research Institute 眼に適用する疾患治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2425849C (en) * 1991-11-22 2007-02-27 Alcon Laboratories, Inc. Angiostatic steroids
US6197833B1 (en) * 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
WO2002042319A2 (en) * 2000-11-27 2002-05-30 Entremed, Inc. 2-substituted estrogens as antiangiogenic agents

Also Published As

Publication number Publication date
ES2289134T3 (es) 2008-02-01
ZA200401313B (en) 2005-05-11
CA2458468C (en) 2010-08-24
CA2458468A1 (en) 2003-03-13
EP1423125B1 (en) 2007-08-29
CN1551773A (zh) 2004-12-01
PL374243A1 (en) 2005-10-03
WO2003020284A1 (en) 2003-03-13
DE60222143D1 (de) 2007-10-11
TWI320712B (en) 2010-02-21
AU2002326807B2 (en) 2007-08-23
PL206249B1 (pl) 2010-07-30
BR0212274A (pt) 2004-10-19
JP2005501888A (ja) 2005-01-20
DE60222143T2 (de) 2008-06-05
EP1423125A1 (en) 2004-06-02
ATE371455T1 (de) 2007-09-15
EP1423125A4 (en) 2005-02-09
KR100894385B1 (ko) 2009-04-22
AR038451A1 (es) 2005-01-19
KR20040033012A (ko) 2004-04-17
MXPA04002098A (es) 2004-06-07

Similar Documents

Publication Publication Date Title
EP1392292A4 (en) PYRANOINDAZOLES AND THEIR USE IN GLAUCOMA TREATMENT
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
EP1390029A4 (en) PHENYLINDOLES FOR THE TREATMENT OF HIV INFECTION
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL196301A0 (en) Medicament for the treatment of hapatitis c
EP1638508A4 (en) SHUNT FOR GLUCKOM TREATMENT
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
AU2002364300A8 (en) Polymer derivatives for the treatment of metals
IL161070A0 (en) Compositions for the treatment of infectious diseases
AU2001272852A1 (en) Composition for the treatment of migraine
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
ZA200307731B (en) Use of selective COX-2inhibitors for the treatment of urinary incontinence.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
EP1461030A4 (en) AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
AU2001293891A1 (en) New combination for the treatment of asthma
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
AU2002364711A8 (en) Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
HK1064947A1 (en) Use of non-feminizing estrogens as retinoprotecti ve agents for the treatment of glaucoma
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU2002365621A8 (en) Composition for treating the surface of the skin
AU2002319169A1 (en) Substituted benzoylketones as herbicidal agents for use as plant treatment agent

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120903